Literature DB >> 2352921

Effect of oltipraz on the susceptibility of adult Schistosoma mansoni to killing by mouse peritoneal exudate cells.

G M Mkoji1, J M Smith, R K Prichard.   

Abstract

Incubation of the adult Schistosoma mansoni with the anti-schistosomal compound oltipraz (OPZ) (40 nM) resulted in a significant decrease in schistosome-reduced glutathione (GSH), a thiol compound which may have a role in protection against oxidant-mediated damage. A significant proportion (20-47%) of worms treated with OPZ became susceptible to in vitro killing by zymosan-stimulated peritoneal exudate cells from mice infected with S. mansoni or inoculated with Bacillus Calmette Guérin (BCG). Killing of the worms was partially inhibited by the addition to the assay system of exogenous glutathione peroxidase with GSH but not by superoxide dismutase. These results suggested that killing of parasites exposed to the drug was partly mediated by cell-generated hydrogen peroxide. They indicate also that depletion of schistosome GSH levels could render the parasites susceptible to killing by oxidative mechanisms, and suggest that there is potential in exploiting schistosome oxidant defense systems and reactive oxygen byproducts in the treatment of schistosomiasis. Inhibition of schistosome oxidant defense systems with drugs may render the parasites susceptible to killing by reactive oxygen byproducts of effector cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352921     DOI: 10.1007/bf00933553

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

1.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

2.  Activated macrophages as effector cells of protective immunity to schistosomiasis.

Authors:  S L James
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Antioxidant systems in Schistosoma mansoni: evidence for their role in protection of the adult worms against oxidant killing.

Authors:  G M Mkoji; J M Smith; R K Prichard
Journal:  Int J Parasitol       Date:  1988-07       Impact factor: 3.981

4.  Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals.

Authors:  G M Mkoji; J M Smith; R K Prichard
Journal:  Int J Parasitol       Date:  1988-07       Impact factor: 3.981

5.  The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms.

Authors:  S R Smithers; R J Terry
Journal:  Parasitology       Date:  1965-11       Impact factor: 3.234

6.  Acute effects of oltipraz on adult Schistosoma mansoni and its antagonism in vitro.

Authors:  D D Morrison; D P Thompson; D R Semeyn; J L Bennett
Journal:  Biochem Pharmacol       Date:  1987-04-01       Impact factor: 5.858

7.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

Authors:  O W Griffith
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

8.  Reduced capacity of peritoneal exudate cells for oxidative killing of Schistosoma mansoni schistosomula.

Authors:  J M Smith; G M Mikoji; R K Prichard
Journal:  Mem Inst Oswaldo Cruz       Date:  1987       Impact factor: 2.743

9.  Schistosoma mansoni: evidence that eosinophils and/or macrophages contribute to skin-phase challenge attrition in vaccinated CBA/Ca mice.

Authors:  R E Ward; D J McLaren
Journal:  Parasitology       Date:  1988-02       Impact factor: 3.234

10.  The antischistosomal activity of oltipraz.

Authors:  E Bueding; P Dolan; J P Leroy
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-08
View more
  1 in total

1.  TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling.

Authors:  Alan R Wolfe; R Jeffrey Neitz; Mark Burlingame; Brian M Suzuki; K C Lim; Mark Scheideler; David L Nelson; Leslie Z Benet; Conor R Caffrey
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-11-20       Impact factor: 4.077

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.